ArticlePLoS computational biology2026
Reassessing adult surfactant replacement therapy with mechanics-informed reinforcement learning.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reassessing adult surfactant replacement therapy with mechanics-informed reinforcement learning.PLoS computational biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Surfactant replacement therapy (SRT) remains clinically limited to neonatal applications, in part because the mechanical feasibility of achieving efficient delivery in adult lungs is poorly understood. Previous computational studies have largely been descriptive or based on parameter sweeps, providing limited guidance on how to design efficient adult protocols under anatomical constraints. Here, we introduce a computational framework that integrates mechanistic modeling of surfactant propagation in anatomically motivated airway trees with deep reinforcement learning (DRL) to identify efficient delivery strategies across scales and airway geometries. The approach leverages a reduced-order model of plug transport and redistribution that captures the key mechanics of surfactant coating in complex airway networks while remaining lightweight enough for large-scale optimization. A custom DRL agent autonomously explores delivery parameters-including aliquot volume, flow rate, patient posture, and surfactant properties-to optimize protocol-level performance across diverse anatomical and physiological conditions. Under the branch-level coverage-based reward adopted here, systematic optimization of delivery parameters improves distal delivery at both pediatric and adult scales, while clarifying how these gains depend on prescribed volume, airway asymmetry, and control complexity. Increasing the number of aliquots improves access to distal regions and, in favorable geometries, shifts the onset of high-coverage regimes toward lower prescribed volumes, whereas posture becomes especially informative in asymmetric trees. Extending the control space to include surfactant rheology provides an additional lever, particularly in constrained adult settings, but does not overcome the structural limitations imposed by strong geometric asymmetry. Overall, these results establish a physics-based framework for AI-assisted optimization of intrapulmonary liquid delivery and clarify the respective roles of dose partitioning, posture, and formulation tuning. They also show that the interpretation of delivery success depends strongly on the evaluation metric: branch-level coverage provides a functionally oriented measure across heterogeneous airway trees, whereas stricter homogeneity metrics yield substantially more pessimistic assessments, especially in adult asymmetric geometries. These findings do not predict clinical efficacy; rather, they provide a controlled mechanistic feasibility benchmark and testable design hypotheses within physiologically realistic bounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.